Category

Uncategorized

Rhea is Back on the Field

Last year, Rhealynn “Rhea” Mills stood in front of 600 guests at the Believe Ball and shared her story. What the room didn’t know that night was that she’d relapsed just one week earlier. Despite this, she showed up anyway, strong and steady, and left an impression none of us has forgotten.

Watch the video we shared that night before she spoke. Knowing what she was carrying that night makes it even more powerful.

A Journey That Began in 2022

Rhea’s story started in October 2022, when she was diagnosed with metastatic osteosarcoma, an aggressive form of bone cancer. Her treatment included the amputation of her right leg, along with multiple surgeries after the cancer spread to her lungs. It’s the kind of diagnosis that reshapes a family overnight, and for the Mills family of Thomasville, Georgia, it did exactly that.

There were dark moments along the way. Rhea has shared that there was a point she thought she was done, and that she might not get to play the sport she loved again. But something in her kept pushing back against that fear, and she decided she wanted to try again.

Where She Is Now

This spring brought a scare: abnormal lab results sent the family back to Texas early, and doctors worried about a possible secondary cancer. After weeks of testing, the news was better than they’d hoped. There is no secondary cancer, and the large tumor in Rhea’s lung appeared to be completely dead. The abnormal labs, it turned out, were caused by low copper levels.

Today, her mother, Revana, reports there’s no active cancer detected, though a mass remains in the left upper lobe of her lung that the family hopes will continue shrinking on its own. Rhea takes daily medication and continues physical therapy to rebuild shoulder strength and manage lingering back pain.

And through all of it, Rhea is back on the softball field. Watch this news feature about Rhea’s return to the mound. You’ll be inspired!

Her mother calls watching that moment one of the most emotional parts of their entire journey. She wondered for so long whether they’d ever get back to the bleachers. Rhea’s own goals are refreshingly simple: get stronger, hit better, pitch better, and maybe one day play ball in college.

A Family That Keeps Choosing Hope

More than 10,000 people now follow Rhea’s story online, where her family shares both the hard days and the joyful ones: fishing trips, horseback riding, golf, and laughter. They’ve recently launched a YouTube channel to keep documenting those moments, hoping their honesty helps other families facing hard days keep fighting.

Rhea has said she loves the idea of inspiring others to keep working. If her story does that for even one more family walking a similar road, it will be doing exactly what she hoped.

2026 Research Awards

CURE Childhood Cancer Invests $5.7 Million to Accelerate New Treatments for Children Facing the Toughest Cancers

CURE Childhood Cancer Invests $5.7 Million to Accelerate New Treatments for Children Facing the Toughest Cancers

For many childhood cancers, progress has transformed what was once considered impossible.

For others, children are still waiting.

This year, CURE Childhood Cancer is investing $5.7 million in research aimed at changing the outlook for children facing some of the most aggressive and difficult-to-treat cancers. The funding will support 18 projects at leading institutions across the country, advancing new therapies, precision medicine approaches, and treatment strategies designed to improve outcomes for children with limited options today. The investment comes at a time when childhood cancer researchers continue to face significant funding challenges despite extraordinary scientific opportunity. More than 200 proposals were submitted for consideration, reflecting both the urgency of the need and the remarkable innovation taking place across the field.

“Our goal is not simply to fund excellent science,” said Kristin Connor, CEO of CURE Childhood Cancer. “We are intentionally investing in opportunities that have the potential to improve outcomes for children facing the cancers that remain the most difficult to cure. These are the children and families who need progress most urgently.”

The projects funded this year target some of pediatric oncology’s greatest challenges, including relapsed and treatment-resistant leukemias, aggressive brain tumors, neuroblastoma, sarcomas, and other high-risk childhood cancers. Researchers are developing next-generation immunotherapies, advancing targeted treatment strategies, overcoming drug resistance, and moving promising discoveries closer to clinical testing. Together, the portfolio reflects a deliberate focus on accelerating progress where the need is greatest and where research has the potential to reach children more quickly.

While childhood cancer survival has improved significantly over the past several decades, outcomes remain unacceptably poor for many children diagnosed with high-risk or relapsed disease. For these families, better treatments cannot come soon enough.

The therapies helping children today exist because researchers were given the resources to pursue bold ideas years ago. CURE’s 2026 research portfolio represents the next generation of those opportunities.

“Every breakthrough begins as an idea,” Connor said. “Our responsibility is to identify the most promising opportunities and help move them forward. We cannot predict which project will lead to the next major advance, but we know progress only happens when great science has the chance to become something more.”

Through this year’s investments, CURE is helping accelerate discoveries that could ultimately lead to new therapies, new clinical trials, and new hope for children facing cancer.

Because every child deserves better options. And every child deserves the chance to benefit from the progress still to come.

CURE’s 2026 RESEARCH AWARDS

Early Investigator Awards

Kelsey Jonus, PhD, Emory University
Development of targeted cell therapy approaches for ATRX mutant neuroblastoma

Gengwen Tian, MD, PhD, Baylor College of Medicine
Enhancing GD2.CAR-NKT anti-tumor efficacy against neuroblastoma and tumor microenvironment through targeting PRDM1 and ZBTB7B

Catherine Carbone, PhD, Seattle Children’s Hospital
Rewiring neuroblastoma immune circuits with tumor arrays

Francesca Alvarez Calderon, MD, PhD, Dana-Farber Cancer Institute
Engineering TCR-T cells to overcome trafficking barriers in Ewing sarcoma

Translation to Clinic Awards

Iannis Aifantis, PhD, NYU Grossman School of Medicine
Targeting antigenic escape to strengthen immunotherapies in pediatric leukemia and lymphoma

Eveline Barbieri, MD, PhD, Baylor College of Medicine
Targeting neutral lipogenesis in MYCN-driven neuroblastoma

Mignon Loh, MD, Seattle Children’s Hospital
Moving affinity-tuned T cell engagers for dual targeting of leukemia closer to clinical trials

Bin Zhang, MD, PhD, Beckman Research Institute of the City of Hope
Developing novel miR-142-armored anti-CD19 CAR T cells to target B-ALL

Jessica Pollard, MD, Dana-Farber Cancer Institute
Phase I Study of Azacitidine and Venetoclax for children, adolescents, and young adults with high-risk myeloid disease

David Langenau, PhD, Massachusetts General Hospital
Metastasis and cell state plasticity in rhabdomyosarcoma

Juan Vasquez, MD, Yale University
Preclinical efficacy of novel pH-sensitive peptide-drug conjugate in pediatric sarcoma and biomarkers of response

Samuel John, MD, The University of Texas Southwestern Medical Center
Dual targeting lymphoid and myeloid antigens by a novel switch adaptor protein for LS acute leukemia

Linda Resar, MD, Johns Hopkins University School of Medicine
Targeting resistance to Menin inhibitors in KMTA2A-r acute myeloid leukemia

Kathleen Sakamoto, MD, PhD, Stanford University
Targeting CREB: CBP interaction for treatment of pediatric AML

Shweta Joshi, PhD, The University of California, San Diego
Overcoming macrophage-mediated resistance to boost chemotherapy in neuroblastoma

David Daniels, MD, PhD, Mayo Clinic
Advancing local drug therapy for pediatric diffuse midline glioma through precision infusion and drug efflux modulation

Yun Huang, PhD, Texas A&M University Health Science Center
Molecular targeting of MiT fusion proteins in translocation renal cell carcinoma

Soheil Meshinchi, MD, PhD, Fred Hutchinson Cancer Center
Development and translational evaluation of CLEC2A-directed ADCs for KMT2A-r AML

I Am Her Strength

Five-year-old De’Meiah (Meme) was in kindergarten when her teacher noticed she wasn’t using her left arm. For her mom, Takia, that small observation set off a medical journey that changed their family forever. When doctors first suggested scoliosis, Takia’s instincts told her something more was going on. She pushed for answers, sought a second opinion, and finally got an MRI. During the scan, Meme had an allergic reaction to the sedation and stopped breathing. A second MRI showed a tumor at the top of Meme’s spine, pressing on the nerve and preventing her from using her arm.

Testing of the tumor revealed that it was not fast-growing, but its location on the spine made its removal impossible. Chemotherapy was the only path forward. Over the past three years, she has reacted well to treatment, but doesn’t like to have her port accessed.

If you spend a few minutes with Meme, you’ll learn she is a diva who loves the camera, dressing up, and the color pink. She’ll dance for you, or she’ll tell you she’s going to be a doctor, a police officer, or a teacher when she grows up. Chemo has made her more home-bound than before. But she’s filled the house with TikTok videos, joyful energy, and a spirit that makes everyone in her life cheer for her. She even worked hard to make the second-grade honor roll.

Behind every child who fights cancer, there is a parent fighting quietly, relentlessly, and sometimes alone. As a single mom, Takia spent the bulk of Meme’s treatment working full-time while getting her to appointments at least twice a week. She recently took a leave of absence so she could be fully present as Meme nears the finish line of her treatment.

Through it all, she has held herself together with intention. She doesn’t cry in front of Meme. She wants her daughter to feed off her strength, not her fear.

“I am her strength,” Takia shared. “I don’t cry when I’m around her. I cry when I’m by myself. But I don’t want her to worry, because she’s the one going through it.”

CURE has walked alongside them every step of the way. For a working single parent navigating treatment, having a team she could count on wasn’t just helpful, it was essential.

“God is good, he has held Meme and me close during this time,” Takia said. “And the CURE team has always been there for us. We felt loved and supported from the day we learned about the tumor.”

On May 14, Meme will ring the bell: a girl who lost the use of her arm and got it back, an honor roll student, and a diva with a bright future ahead. And she will ring it as the daughter of Takia, a mother who never stopped fighting for answers and has stayed strong when it was hardest.

This Mother’s Day, we celebrate them both.

The Little Iron Horse

Ripken was named after a legendary baseball player known for being a man of high character and playing through aches and pain. During his playing days, he earned the nickname Iron Horse for setting baseball’s record for consecutive games played.

At three years old, Ripken was the embodiment of energy, joy, and the tenacity of his namesake. He was never moody or whiny. When his demeanor changed that summer weekend at the lake, his mother, Hannah, knew something was wrong.

Instead of running and playing with friends, Ripken just wanted to be held. He also had severe bruising that Hannah didn’t feel was a result of normal activities. When she took him to the doctor for what she thought might be an iron deficiency, his hemoglobin came back critically low, and his doctor sent them to the emergency room.

On July 31, 2024, Ripken was officially diagnosed with leukemia. Hannah’s instincts had caught it early, but that didn’t make the diagnosis any less devastating for his family. That’s when CURE stepped in. Their first interaction came through meals in the hospital, a simple gesture that helped lift spirits during the darkest days. But CURE’s impact went far beyond food. They became a constant presence, always around to offer a listening ear or a comforting hug exactly when Hannah needed it most.

“CURE has been an amazing organization to help us get through the worst time in our lives,” Hannah reflects.

Through it all, Ripken has been a trooper. Though his chemotherapy sometimes makes him moody, he’s responded well to treatment. A compromised immune system forced him to stay at home for a year. But now he is back in daycare, staying healthy, and already swinging at baseballs and golf balls in the yard.

Just like the Iron Horse whose name he carries, Ripken shows what it means to live through pain with grace, grit, and an unbreakable spirit.

A Family Tradition of Service

Four Savannah Students Carry the Torch for CURE Childhood Cancer

What began as a simple decision by one Savannah high school student has grown into a family legacy of service and compassion.

When St. Vincent’s Academy student Grace Mahfet applied to serve on CURE Childhood Cancer’s CURE Crew in 2021 as a rising junior, she had no idea she was beginning a volunteer tradition that would span five years and inspire three members of her family to follow in her footsteps.

CURE Crew is a teen leadership council that helps the organization raise awareness about pediatric cancer while supporting it through fundraising, advocacy, and volunteer service. Guided by CURE’s staff, Grace became a dedicated ambassador for the cause both in the Savannah community and at her school.

After her first year of service, Grace encouraged her cousin Julia Ronning, then a rising junior at Savannah Christian Preparatory School, to apply as well. The two served side by side, volunteering at events and helping spread CURE’s mission throughout their schools.

Their tradition of service didn’t stop after graduation. Grace went on to attend the University of Georgia, and Julia joined her the following year. Both have continued their commitment to philanthropy through their sorority. Soon, the next generation of volunteers was ready to step up.

With Grace and Julia at UGA, their younger brothers, Joe Joe Mahfet, a student at Benedictine Military School, and Max Ronning, a student at Savannah Arts Academy, joined the CURE Crew.

Now nearing the completion of their own two years of service with CURE Crew, both boys have become standout leaders within the program. Max and Joe Joe served as Senior Crew Leaders this year, helping guide younger members while continuing to volunteer at CURE events throughout the community.

“Max and Joe Joe are both just amazing young men with servants’ hearts,” Said Mandy Garola, CURE’s Vice President. “They show up, communicate well, work hard, and are friendly and cheerful. We’re lucky to have had all four of the Mahfet and Ronning students working with CURE. What a wonderful family and outstanding kids. These four will go far in life. I wish there were more of them.”

Both boys plan to continue the family tradition and join their sisters at the University of Georgia in the fall.

“I saw the impact CURE was having in the community while Julia was volunteering,” Max said. “It was exciting, and I wanted to be a part of it.”

“My biggest takeaway from volunteering with CURE is that we need more funding for better pediatric cancer treatments,” Joe Joe realized. “These kids deserve to go on and lead long, full lives.”

And that is exactly the future CURE is working toward.

Thanks to young leaders like Grace, Julia, Joe Joe, and Max, that mission continues to gain strength – one generation at a time.

Addy’s Army Joins Forces with CURE

Addison “Addy” Tomberlin was born on November 14, 2012, and from the very beginning, she filled every room she entered with light. She was a healthy, happy little girl with a beautiful soul, completely adored by her family and everyone fortunate enough to know her.

Her world changed on May 29, 2016, when Addy was just 3½ years old. She was diagnosed with acute lymphocytic leukemia, but not the most common and treatable type. The overall survival rate for childhood ALL is approximately 90%. But testing revealed that her leukemia was Philadelphia chromosome positive. This rare and aggressive variant required an intense, prolonged treatment plan and carried a much worse prognosis.

Addy started more than two years of relentless chemotherapy and spent more than 250 days in the hospital. Her tiny body endured more than any child ever should. Yet even in the hardest moments, Addy smiled through exhaustion, laughed through pain, and taught everyone around her what true strength looks like.

Eleven months after completing treatment, Addy relapsed. The toll of years of chemotherapy had left her body fragile, and within weeks, she was in the ICU with heart failure. But hope arrived just in time. A groundbreaking clinical study had opened for children with her type of leukemia: CAR-T cell therapy. It worked. For four beautiful years, Addy lived her absolute best life. She was happy, healthy, and cancer-free.

But on August 26, 2023, her cancer returned. True to form, Addy faced it with the same courage, love, and joy that had always defined her. This time, there was no clinical trial for her, and she passed away less than a month later.

Addy’s time here was far too brief, but her impact is immeasurable. In her honor, her family established Addy’s Army Fund at CURE. The fund advances childhood cancer research with a focus on innovative treatments – like precision medicine and immunotherapies that are more effective and less damaging to growing bodies. It also supports quality-of-life programs for children in treatment, resources for siblings silently affected by a loved one’s diagnosis, and bereavement support for grieving families.

There is no doubt that Addy’s life and light changed lives. Now, her Army carries her mission into battle for other families faced with the same fight.

United in Gold

How Our Community Made September 2025 Unforgettable

Every year, we get geared up for September’s Childhood Cancer Awareness Month, and when the month ends, we’re overwhelmed by your outpouring of kindness and support. 2025 was no exception, as you showed us how our community comes together to fight for children with cancer.

Picture this: 6,200 CURE Flags standing tall in neighborhoods across the country. For families navigating their cancer journey, each flag said, “You’re not alone. We see you, and we’re fighting alongside you.” Together, these flags lifted spirits and raised an incredible $206,800 for the fight against childhood cancer. And for the first time, a CURE Flag flew in all 50 states!

Our September Community Partners transformed everyday moments into opportunities for impact. Whether you enjoyed a meal at a favorite restaurant, grabbed your morning coffee, or dropped spare change into a Coins4CURE collection, you made fighting childhood cancer part of your daily routine. Through these partnerships, you helped raise more than $57,000 to advance our mission.

The Hero Wall shared our brave CURE Kids stories, and you responded with remarkable generosity, contributing over $10,000 to fuel critical research and support families who need it most.

The 2025 Corporate Challenge brought together companies across the region for friendly competition and raised more than $108,000! The dedication and competitive spirit of each business will fuel groundbreaking research and provide crucial support to families facing childhood cancer. Congratulations to our Grand Champion, Deloitte, for raising an incredible $26,356!

Students and communities carried the banner of hope through 15 Gold Out games. From the Savannah area to communities throughout the state, these touching tributes reminded us that students, parents, teachers, and fans are united in this fight. Many of the games hosted honored children and showed them a wonderful time.

Each of your individual actions, whether buying a flag, supporting a business partner, attending a Gold Out game, or competing with colleagues, merged into something powerful. Together, you’ve proven that when it comes to our fight, there are no small contributions, only the incredible impact we create when children are the focus.

Thank you for joining us. Your compassion and dedication continue to light the way toward a better tomorrow for children with cancer.

2025 Research Awards

CURE Childhood Cancer is thrilled to announce a remarkable achievement in our 50-year mission to end childhood cancer: a $5.6 million investment in lifesaving research studies.

These 13 innovative research projects are led by renowned scientists at premier pediatric cancer research institutions across the country and target the most urgent challenges facing young patients. What makes this investment so powerful is that every project is designed with the goal of helping children within the next 2-3 years – not decades from now. All proposals underwent rigorous review by CURE’s Peer Review Committee, comprised of practicing pediatric oncologists and academic researchers.

For families facing devastating diagnoses, this funding represents real hope, not someday, but soon. Thank you for making this breakthrough investment possible.

“We are proud to partner with some of the brightest minds in pediatric cancer research – scientists who have devoted their lives to solving the most difficult challenges children with cancer face,” said Kristin Connor, CEO of CURE Childhood Cancer. “With so little federal funding directed toward pediatric cancers, our support is often the catalyst that allows critical science to move forward. We are laser-focused on changing the odds for children with few treatment options and on discovering therapies that don’t leave devastating lifelong side effects. It’s because of our incredible community of supporters that we can fuel this progress and continue pushing toward the day when every child has the chance to be cured.”

Thank you for being an essential part of this journey.

CURE’s 2025 RESEARCH AWARDS

Early Investigator Awards

Emily Heikamp, MD, PhD, Dana-Farber Cancer Institute
Targeting chromatin regulators of oncogenic transcription in NUP98-rearranged leukemia

Nathaniel Mabe, PhD, Purdue University
Selective targeting of epigenetic pathways underlying drug tolerant persistence in neuroblastoma

Palaniraja Thandapani, PhD, The University of Texas MD Anderson Cancer Center
Targeting Proline tRNA Biogenesis as a Therapeutic Strategy in NOTCH1-Driven T-ALL

Translation to Clinic Awards

Manoj Bhasin, PhD, MS, Emory University
Interrogation of mast cells as a high-risk biomarker in core binding factor mutated pediatric acute myeloid leukemia

Kelly Goldsmith, MD, Emory University
Companion Molecular Imaging for PTK7 Targeted Immunotherapies in Pediatric Solid Tumors

Rintaro Hashizume, MD, PhD, University of Alabama at Birmingham
Intranasal Delivery of Targeted Nanotherapeutics and Oncolytic Virus in Pediatric Glioma

Raushan Kurmasheva, PhD, University of Texas Health Science Center at San Antonio
Advancing Innovative and Effective Therapies for Children with Malignant Rhabdoid Tumors

Kathy Fange Liu, PhD, University of Pennsylvania
METTL3-targeting ASOs and synthetic lethality approaches in pediatric neuroblastoma

Paul Sondel, MD, PhD, University of Wisconsin-Madison
Novel GD2/B7-H3 Bispecific Antibody with Agonist CD40 Antibody, Epigenetic Modifier Inhibitors and Checkpoint Blockade to Improve Treatment Efficacy for High-Risk Neuroblastoma

Michael Verneris, MD, University of Colorado Denver
Translational Strategies To Enhance B7-H3-CXCR2 CAR T Homing and Function in Sarcoma

Elvin Wagenblast, PhD, Icahn School of Medicine at Mount Sinai
PR Domain Inhibition to Target Leukemia Stem Cells in Pediatric Acute Myeloid Leukemia

Muxiang Zhou, MD, Emory University
Dual inhibition of MDM2 and tubulin for precision treatment of acute myeloid leukemia

Precision Medicine Program, Children’s Healthcare of Atlanta
A program leveraging genomic sequencing for pediatric patients with high-risk tumors, with the goal of identifying alterations that can impact therapies and improve outcomes.

Stitching Hope

Local Teens Create Comfort Wear for Young Cancer Patients

A group of longtime friends at Savannah Country Day School are putting their hearts, hands, and sewing machines to work for young cancer patients in their community. The initiative, called Care Wear for CURE, was born when sophomore Margaret and her mother came up with an idea to create comfortable, port-friendly clothing for children undergoing cancer treatment.

What started as a learning experience with two of their grandmothers has blossomed into a full-fledged mission. The team of young ladies – Margaret, Olivia, Tennyson, Clara, Saylor, and Katherine – have been friends since their early school days, and now they’re channeling their friendship into a force for good.

The project got an early boost when a company generously donated shirts and dresses for the girls to practice their sewing skills. Through trial and error, and with guidance from their experienced grandmothers, they refined their approach. They discovered that snap closures were more comfortable than zippers for young patients, and they added special pockets that could hold small toys so the child could keep their favorite things close by.

The enthusiasm of these young entrepreneurs is infectious. They’ve created an Instagram page that’s already attracting support, with high school students sending spontaneous donations. To raise additional funds, the girls have organized bake sales and crafted necklaces, using the proceeds to create more clothing and assemble tote bags filled with toys and gift cards for families in treatment. You can find them on Instagram as @carewearforcure.

So far, the team has completed ten pieces and is now working on customizable clothing, incorporating each child’s favorite colors and interests into the designs. They’re even planning to expand their line to include pajamas through a partnership with a Savannah-based favorite, LAKE Pajamas. They were recently able to deliver the first sets to children in treatment at Memorial Health Dwaine & Cynthia Willett Children’s Hospital of Savannah.

This initiative is particularly special because it brings together multiple generations –grandmothers passing down their sewing skills, mothers supporting their daughters’ vision, and young women using these gifts to comfort children. Care Wear for CURE shows that sometimes the most meaningful projects begin with a simple idea and a willing heart.

A Heart that Beat for Others

In the world of childhood cancer, heroes come in many forms. Some wear white coats, others don nursing scrubs, and then there are those who wield drumsticks and a heart of gold. Brit Turner, the founding drummer of Blackberry Smoke, was one such hero — a man whose rhythm not only moved feet but also touched countless hearts.

Brit’s journey with CURE began in 2009 when his daughter was diagnosed with stage-4 neuroblastoma. For two grueling years, the Turner family navigated the storm of childhood cancer, finally reaching remission. But for Brit, this wasn’t the end of the story — it was just the beginning.

Where others might have stepped back, grateful for their own child’s recovery, Brit stepped forward. He made a promise: “When my daughter was diagnosed, I felt completely helpless and I made a promise to help people going through the same thing.” It was a promise he kept until his last breath.

Through Blackberry Smoke, Brit orchestrated the raising and donating of over $700,000 to childhood cancer organizations. But numbers, impressive as they are, fail to capture the essence of Brit’s impact. It was in the quiet, often anonymous acts of kindness that Brit’s true character shone brightest.

Picture a single mother struggling to keep a roof over her family’s head while her child battles cancer. Brit, moved to tears by her story, silently paid this stranger’s mortgage for six months. Or the hundreds of nurses at the Aflac Cancer Center receiving light-up shoes — a gesture of appreciation from a man most had never met. These weren’t publicity stunts; they were the actions of a man whose empathy knew no bounds.

Brit had a unique ability to turn conversations away from himself, always more interested in the stories and needs of others. When we shared tales of families in need, Brit’s eyes would immediately well up. His response was always the same: “What can we do to help?”

Even when faced with his own glioblastoma diagnosis in 2022, Brit’s resolve to help children with cancer only strengthened. He approached his own battle with the same courage and grace he had witnessed in so many children, all while continuing his mission to support others.

To us at CURE, Brit wasn’t just a supporter or a donor — he was family. He was the brother who shows up unannounced with exactly what you need, the friend who listens without judgment, and the warrior who fights tirelessly for a cause bigger than himself.

As we move forward, we carry Brit’s spirit with us. The Brit Turner Family Fund at CURE will continue his legacy, helping children and families who need it most. But perhaps the greatest tribute we can pay to Brit is to approach our mission with the same love, empathy, and selflessness that he exemplified every day.

Brit Turner left an indelible mark on the childhood cancer community — not just through his music or his fundraising, but through the countless lives he touched with his kindness and compassion. He showed us that true heroism lies in the quiet, consistent acts of love that change lives one at a time.

*In loving memory of Brit Turner (1967-2024) — a devoted father and husband, a talented musician, a tireless advocate, and a true friend to all who knew him and to countless others he never met but held close to his heart.

Learn more about the Brit Turner Family Fund

LEARN MORE